Literature DB >> 20229133

St. John's Wort constituents modulate P-glycoprotein transport activity at the blood-brain barrier.

Melanie Ott1, Miriam Huls, Michael G Cornelius, Gert Fricker.   

Abstract

PURPOSE: The purpose of this study was to investigate the short-term signaling effects of St. John's Wort (SJW) extract and selected SJW constituents on the blood-brain barrier transporter P-glycoprotein and to describe the role of PKC in the signaling.
METHODS: Cultured porcine brain capillary endothelial cells (PBCEC) and freshly isolated brain capillaries from pig were used as in vitro/ex vivo blood-brain barrier model. SJW modulation of P-glycoprotein function was studied in PBCEC using a calcein-AM uptake assay and in isolated pig brain capillaries using the fluorescent cyclosporine A derivative NBD-CSA and confocal microscopy.
RESULTS: SJW extract and the constituents hyperforin, hypericin, and quercetin decreased P-glycoprotein transport activity in a dose- and time-dependent manner. SJW extract and hyperforin directly inhibited P-glycoprotein activity, whereas hypericin and quercetin modulated transporter function through a mechanism involving protein kinase C. Quercetin at high concentrations decreased P-glycoprotein transport activity, but increased transporter function at low concentrations. This increase in P-glycoprotein activity was likely due to trafficking and membrane insertion of vesicles containing transporter protein.
CONCLUSIONS: Our findings provide new insights into the short-term interaction of SJW with P-glycoprotein at the blood-brain barrier. They are of potential relevance given the wide use of SJW as OTC medication and the importance P-glycoprotein has for CNS therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20229133     DOI: 10.1007/s11095-010-0074-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  43 in total

1.  Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

Authors:  D S Miller; S N Nobmann; H Gutmann; M Toeroek; J Drewe; G Fricker
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

2.  Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.

Authors:  Hans-Ulrich Schulz; Michael Schürer; Dagmar Bässler; Dieter Weiser
Journal:  Arzneimittelforschung       Date:  2005

3.  St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.

Authors:  L B Moore; B Goodwin; S A Jones; G B Wisely; C J Serabjit-Singh; T M Willson; J L Collins; S A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

4.  Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.

Authors:  M Essodaigui; H J Broxterman; A Garnier-Suillerot
Journal:  Biochemistry       Date:  1998-02-24       Impact factor: 3.162

5.  In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation.

Authors:  Björn Bauer; Xiaodong Yang; Anika M S Hartz; Emily R Olson; Rong Zhao; J Cory Kalvass; Gary M Pollack; David S Miller
Journal:  Mol Pharmacol       Date:  2006-07-12       Impact factor: 4.436

Review 6.  St John's wort for depression: meta-analysis of randomised controlled trials.

Authors:  Klaus Linde; Michael Berner; Matthias Egger; Cynthia Mulrow
Journal:  Br J Psychiatry       Date:  2005-02       Impact factor: 9.319

7.  Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1.

Authors:  Z Holló; L Homolya; T Hegedûs; M Müller; G Szakács; K Jakab; F Antal; B Sarkadi
Journal:  Anticancer Res       Date:  1998 Jul-Aug       Impact factor: 2.480

8.  Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1.

Authors:  Anika M S Hartz; Björn Bauer; Gert Fricker; David S Miller
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

Review 9.  Drug interactions with St John's wort : mechanisms and clinical implications.

Authors:  Marcus Mannel
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

10.  Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells.

Authors:  Claire Quiney; Christian Billard; Anne-Marie Faussat; Célia Salanoubat; Jean-Pierre Kolb
Journal:  Leuk Lymphoma       Date:  2007-08
View more
  10 in total

Review 1.  Drug interactions with herbal medicines.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2012-02-01       Impact factor: 6.447

2.  Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model.

Authors:  Deepak Chitkara; Sanjay K Nikalaje; Anupama Mittal; Mahesh Chand; Neeraj Kumar
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

3.  Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice.

Authors:  Jacqueline Hofrichter; Markus Krohn; Toni Schumacher; Cathleen Lange; Björn Feistel; Bernd Walbroel; Hans-Jochen Heinze; Sara Crockett; Timothy F Sharbel; Jens Pahnke
Journal:  Curr Alzheimer Res       Date:  2013-12       Impact factor: 3.498

4.  Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.

Authors:  Zahra Kiasalari; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Cell Mol Neurobiol       Date:  2015-06-29       Impact factor: 5.046

5.  Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).

Authors:  Andaleeb Sajid; Natarajan Raju; Sabrina Lusvarghi; Shahrooz Vahedi; Rolf E Swenson; Suresh V Ambudkar
Journal:  Drug Metab Dispos       Date:  2019-08-01       Impact factor: 3.922

Review 6.  Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer's disease management.

Authors:  Sumit Jain; Vijay Rathod; Rameshwar Prajapati; Prajwal P Nandekar; Abhay T Sangamwar
Journal:  Mol Divers       Date:  2014-09-12       Impact factor: 2.943

7.  Influence of St. John's Wort on Intravenous Fentanyl Pharmacokinetics, Pharmacodynamics, and Clinical Effects: A Randomized Clinical Trial.

Authors:  Michael J Loughren; Evan D Kharasch; Megan C Kelton-Rehkopf; Karen L Syrjala; Danny D Shen
Journal:  Anesthesiology       Date:  2020-03       Impact factor: 7.892

8.  Drug-induced trafficking of p-glycoprotein in human brain capillary endothelial cells as demonstrated by exposure to mitomycin C.

Authors:  Andreas Noack; Sandra Noack; Andrea Hoffmann; Katia Maalouf; Manuela Buettner; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Dana Alms; Kerstin Römermann; Hassan Y Naim; Wolfgang Löscher
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

Review 9.  Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.

Authors:  Abdullah Mayati; Amélie Moreau; Marc Le Vée; Bruno Stieger; Claire Denizot; Yannick Parmentier; Olivier Fardel
Journal:  Int J Mol Sci       Date:  2017-04-04       Impact factor: 5.923

Review 10.  Clinical relevance of St. John's wort drug interactions revisited.

Authors:  Simon Nicolussi; Jürgen Drewe; Veronika Butterweck; Henriette E Meyer Zu Schwabedissen
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.